ArticleFrontiers in oncology2026

MYH9 confers doxorubicin resistance by stabilizing GRP78 and suppressing the PERK signaling-driven apoptotic pathway in breast cancer.

Jing Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.